Sunil Agarwal's most recent trade in Astria Therapeutics Inc was a trade of 26,550 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Astria Therapeutics Inc | Sunil Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 26,550 | 26,550 | - | - | Stock Option (Right to Buy) | |
| Arvinas Inc | Sunil Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 9,070 | 9,070 | - | - | Stock Option (right to buy) | |
| Arvinas Inc | Sunil Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 5,899 | 14,141 (0%) | 0% | 0 | Common Stock | |
| Astria Therapeutics Inc | Sunil Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 28,200 | 28,200 | - | - | Stock Option (Right to Buy) | |
| Arvinas Inc | Sunil Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 24,948 | 24,948 | - | - | Stock Option (right to buy) | |
| Arvinas Inc | Sunil Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,242 | 8,242 (0%) | 0% | 0 | Common Stock | |
| Sana Biotechnology Inc | Sunil Agarwal | EVP, Head of Development & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 250,000 | 250,000 | - | - | Stock Options (Right to Buy) | |
| Sana Biotechnology Inc | Sunil Agarwal | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 76,682 | 76,682 | - | - | Stock Option (Right to Buy) |